167 related articles for article (PubMed ID: 35616744)
21. Prophylactic mastectomy in patients at high risk: is there a role for sentinel lymph node biopsy?
Murthy V; Chamberlain RS
Clin Breast Cancer; 2013 Jun; 13(3):180-7. PubMed ID: 23357305
[TBL] [Abstract][Full Text] [Related]
22. Occult disease in reduction mammoplasties and prophylactic mastectomies.
Nomikos A; Husain EA; Graham AD
Breast J; 2020 Apr; 26(4):691-696. PubMed ID: 31448509
[TBL] [Abstract][Full Text] [Related]
23. Utility and Outcomes of Preoperative Screening Breast MRI for Planned Bilateral Prophylactic Mastectomy in High-Risk Patients.
Taliaferro AS; Price ER; Hayward JH; Wong JM; Balassanian R; Fay JS; Freimanis RI; Joe BN; Lee AY
AJR Am J Roentgenol; 2022 Feb; 218(2):241-248. PubMed ID: 34523953
[No Abstract] [Full Text] [Related]
24. Psychological distress and decision-making factors for prophylactic bilateral mastectomy in cancer-unaffected BRCA1/2 pathogenic variant carriers.
Isselhard A; Tüchler A; Dick J; Scherer A; Aue V; Schmutzler RK; Rhiem K
Psychooncology; 2023 Apr; 32(4):640-648. PubMed ID: 36774644
[TBL] [Abstract][Full Text] [Related]
25. Trends and timing of risk-reducing mastectomy uptake in unaffected BRCA1 and BRCA2 carriers in Slovenia.
Ložar T; Žgajnar J; Perhavec A; Blatnik A; Novaković S; Krajc M
Eur J Surg Oncol; 2021 Aug; 47(8):1900-1906. PubMed ID: 33812767
[TBL] [Abstract][Full Text] [Related]
26. Meta-analysis of sentinel lymph node biopsy at the time of prophylactic mastectomy of the breast.
Zhou WB; Liu XA; Dai JC; Wang S
Can J Surg; 2011 Oct; 54(5):300-6. PubMed ID: 21651834
[TBL] [Abstract][Full Text] [Related]
27. High rate of occult cancer found in prophylactic mastectomy specimens despite thorough presurgical assessment with MRI and ultrasound: findings from the Hereditary Breast and Ovarian Cancer Registration 2016 in Japan.
Yamauchi H; Okawa M; Yokoyama S; Nakagawa C; Yoshida R; Suzuki K; Nakamura S; Arai M
Breast Cancer Res Treat; 2018 Dec; 172(3):679-687. PubMed ID: 30203341
[TBL] [Abstract][Full Text] [Related]
28. Sentinel lymph node biopsy during prophylactic mastectomy: is there a role?
Bunting PW; Cyr AE; Gao F; Margenthaler JA
J Surg Oncol; 2014 Jun; 109(8):747-50. PubMed ID: 24535940
[TBL] [Abstract][Full Text] [Related]
29. A Look at the Other Side: High-Risk Lesions and Occult Contralateral Malignancy in Symmetry Procedures for Patients Undergoing Oncoplastic Breast-Conserving Surgery.
Jackson KM; Millen JC; Orozco JIJ; Stern SL; Fancher CE; Grumley JG
Ann Surg Oncol; 2023 Oct; 30(10):6159-6166. PubMed ID: 37535266
[TBL] [Abstract][Full Text] [Related]
30. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy.
Dupont EL; Kuhn MA; McCann C; Salud C; Spanton JL; Cox CE
Am J Surg; 2000 Oct; 180(4):274-7. PubMed ID: 11113434
[TBL] [Abstract][Full Text] [Related]
31. Is Sentinel Lymph Node Biopsy Necessary in Patients Undergoing Prophylactic Mastectomy? A Systematic Review and Meta-Analysis.
Nagaraja V; Edirimanne S; Eslick GD
Breast J; 2016; 22(2):158-65. PubMed ID: 26748493
[TBL] [Abstract][Full Text] [Related]
32. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.
Hartmann LC; Sellers TA; Schaid DJ; Frank TS; Soderberg CL; Sitta DL; Frost MH; Grant CS; Donohue JH; Woods JE; McDonnell SK; Vockley CW; Deffenbaugh A; Couch FJ; Jenkins RB
J Natl Cancer Inst; 2001 Nov; 93(21):1633-7. PubMed ID: 11698567
[TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital.
Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J
Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482
[TBL] [Abstract][Full Text] [Related]
35. Use of bilateral prophylactic nipple-sparing mastectomy in patients with high risk of breast cancer.
Valero MG; Moo TA; Muhsen S; Zabor EC; Stempel M; Pusic A; Gemignani ML; Morrow M; Sacchini V
Br J Surg; 2020 Sep; 107(10):1307-1312. PubMed ID: 32432359
[TBL] [Abstract][Full Text] [Related]
36. Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study.
Jakub JW; Peled AW; Gray RJ; Greenup RA; Kiluk JV; Sacchini V; McLaughlin SA; Tchou JC; Vierkant RA; Degnim AC; Willey S
JAMA Surg; 2018 Feb; 153(2):123-129. PubMed ID: 28903167
[TBL] [Abstract][Full Text] [Related]
37. Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years.
Petridis C; Arora I; Shah V; Megalios A; Moss C; Mera A; Clifford A; Gillett C; Pinder SE; Tomlinson I; Roylance R; Simpson MA; Sawyer EJ
Breast Cancer Res; 2019 May; 21(1):58. PubMed ID: 31060593
[TBL] [Abstract][Full Text] [Related]
38. Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy.
King TA; Ganaraj A; Fey JV; Tan LK; Hudis C; Norton L; Cody HS; Borgen PI
Cancer; 2004 Sep; 101(5):926-33. PubMed ID: 15329899
[TBL] [Abstract][Full Text] [Related]
39. Predictors for contralateral prophylactic mastectomy in breast cancer patients.
Fu Y; Zhuang Z; Dewing M; Apple S; Chang H
Int J Clin Exp Pathol; 2015; 8(4):3748-64. PubMed ID: 26097557
[TBL] [Abstract][Full Text] [Related]
40. Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis.
Shin YD; Lee HM; Choi YJ
BMC Surg; 2021 Mar; 21(1):159. PubMed ID: 33752671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
